2023-04-012024-03-312024-03-31false08461130GOODWIN HEALTHCARE SERVICES LTD2024-10-2978200iso4217:GBPxbrli:pure084611302023-04-01084611302024-03-31084611302023-04-012024-03-31084611302022-04-01084611302023-03-31084611302022-04-012023-03-3108461130bus:SmallEntities2023-04-012024-03-3108461130bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3108461130bus:AbridgedAccounts2023-04-012024-03-3108461130bus:PrivateLimitedCompanyLtd2023-04-012024-03-3108461130core:WithinOneYear2024-03-3108461130core:AfterOneYear2024-03-3108461130core:WithinOneYear2023-03-3108461130core:AfterOneYear2023-03-3108461130core:ShareCapital2024-03-3108461130core:SharePremium2024-03-3108461130core:RevaluationReserve2024-03-3108461130core:OtherReservesSubtotal2024-03-3108461130core:RetainedEarningsAccumulatedLosses2024-03-3108461130core:ShareCapital2023-03-3108461130core:SharePremium2023-03-3108461130core:RevaluationReserve2023-03-3108461130core:OtherReservesSubtotal2023-03-3108461130core:RetainedEarningsAccumulatedLosses2023-03-3108461130core:LandBuildings2024-03-3108461130core:PlantMachinery2024-03-3108461130core:Vehicles2024-03-3108461130core:FurnitureFittings2024-03-3108461130core:OfficeEquipment2024-03-3108461130core:NetGoodwill2024-03-3108461130core:IntangibleAssetsOtherThanGoodwill2024-03-3108461130core:ListedExchangeTraded2024-03-3108461130core:UnlistedNon-exchangeTraded2024-03-3108461130core:LandBuildings2023-03-3108461130core:PlantMachinery2023-03-3108461130core:Vehicles2023-03-3108461130core:FurnitureFittings2023-03-3108461130core:OfficeEquipment2023-03-3108461130core:NetGoodwill2023-03-3108461130core:IntangibleAssetsOtherThanGoodwill2023-03-3108461130core:ListedExchangeTraded2023-03-3108461130core:UnlistedNon-exchangeTraded2023-03-3108461130core:LandBuildings2023-04-012024-03-3108461130core:PlantMachinery2023-04-012024-03-3108461130core:Vehicles2023-04-012024-03-3108461130core:FurnitureFittings2023-04-012024-03-3108461130core:OfficeEquipment2023-04-012024-03-3108461130core:NetGoodwill2023-04-012024-03-3108461130core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108461130core:ListedExchangeTraded2023-04-012024-03-3108461130core:UnlistedNon-exchangeTraded2023-04-012024-03-3108461130core:MoreThanFiveYears2023-04-012024-03-3108461130core:Non-currentFinancialInstruments2024-03-3108461130core:Non-currentFinancialInstruments2023-03-3108461130dpl:CostSales2023-04-012024-03-3108461130dpl:DistributionCosts2023-04-012024-03-3108461130core:LandBuildings2023-04-012024-03-3108461130core:PlantMachinery2023-04-012024-03-3108461130core:Vehicles2023-04-012024-03-3108461130core:FurnitureFittings2023-04-012024-03-3108461130core:OfficeEquipment2023-04-012024-03-3108461130dpl:AdministrativeExpenses2023-04-012024-03-3108461130core:NetGoodwill2023-04-012024-03-3108461130core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108461130dpl:GroupUndertakings2023-04-012024-03-3108461130dpl:ParticipatingInterests2023-04-012024-03-3108461130dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108461130core:ListedExchangeTraded2023-04-012024-03-3108461130dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108461130core:UnlistedNon-exchangeTraded2023-04-012024-03-3108461130dpl:CostSales2022-04-012023-03-3108461130dpl:DistributionCosts2022-04-012023-03-3108461130core:LandBuildings2022-04-012023-03-3108461130core:PlantMachinery2022-04-012023-03-3108461130core:Vehicles2022-04-012023-03-3108461130core:FurnitureFittings2022-04-012023-03-3108461130core:OfficeEquipment2022-04-012023-03-3108461130dpl:AdministrativeExpenses2022-04-012023-03-3108461130core:NetGoodwill2022-04-012023-03-3108461130core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3108461130dpl:GroupUndertakings2022-04-012023-03-3108461130dpl:ParticipatingInterests2022-04-012023-03-3108461130dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3108461130core:ListedExchangeTraded2022-04-012023-03-3108461130dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3108461130core:UnlistedNon-exchangeTraded2022-04-012023-03-3108461130core:NetGoodwill2024-03-3108461130core:IntangibleAssetsOtherThanGoodwill2024-03-3108461130core:LandBuildings2024-03-3108461130core:PlantMachinery2024-03-3108461130core:Vehicles2024-03-3108461130core:FurnitureFittings2024-03-3108461130core:OfficeEquipment2024-03-3108461130core:AfterOneYear2024-03-3108461130core:WithinOneYear2024-03-3108461130core:ListedExchangeTraded2024-03-3108461130core:UnlistedNon-exchangeTraded2024-03-3108461130core:ShareCapital2024-03-3108461130core:SharePremium2024-03-3108461130core:RevaluationReserve2024-03-3108461130core:OtherReservesSubtotal2024-03-3108461130core:RetainedEarningsAccumulatedLosses2024-03-3108461130core:NetGoodwill2023-03-3108461130core:IntangibleAssetsOtherThanGoodwill2023-03-3108461130core:LandBuildings2023-03-3108461130core:PlantMachinery2023-03-3108461130core:Vehicles2023-03-3108461130core:FurnitureFittings2023-03-3108461130core:OfficeEquipment2023-03-3108461130core:AfterOneYear2023-03-3108461130core:WithinOneYear2023-03-3108461130core:ListedExchangeTraded2023-03-3108461130core:UnlistedNon-exchangeTraded2023-03-3108461130core:ShareCapital2023-03-3108461130core:SharePremium2023-03-3108461130core:RevaluationReserve2023-03-3108461130core:OtherReservesSubtotal2023-03-3108461130core:RetainedEarningsAccumulatedLosses2023-03-3108461130core:NetGoodwill2022-04-0108461130core:IntangibleAssetsOtherThanGoodwill2022-04-0108461130core:LandBuildings2022-04-0108461130core:PlantMachinery2022-04-0108461130core:Vehicles2022-04-0108461130core:FurnitureFittings2022-04-0108461130core:OfficeEquipment2022-04-0108461130core:AfterOneYear2022-04-0108461130core:WithinOneYear2022-04-0108461130core:ListedExchangeTraded2022-04-0108461130core:UnlistedNon-exchangeTraded2022-04-0108461130core:ShareCapital2022-04-0108461130core:SharePremium2022-04-0108461130core:RevaluationReserve2022-04-0108461130core:OtherReservesSubtotal2022-04-0108461130core:RetainedEarningsAccumulatedLosses2022-04-0108461130core:AfterOneYear2023-04-012024-03-3108461130core:WithinOneYear2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108461130core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108461130core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108461130core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108461130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108461130core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108461130core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108461130core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108461130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108461130core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108461130core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3108461130core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3108461130core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3108461130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3108461130core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3108461130core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3108461130core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3108461130core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3108461130core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3108461130bus:Director12023-04-012024-03-3108461130bus:Director22023-04-012024-03-31

GOODWIN HEALTHCARE SERVICES LTD

Registered Number
08461130
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

GOODWIN HEALTHCARE SERVICES LTD
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

GOODWIN, Matthew David
MILLINGTON, Claire

Registered Address

Suite 8 Normanby Gateway
Lysaghts Way
Scunthorpe
DN15 9YG

Registered Number

08461130 (England and Wales)
GOODWIN HEALTHCARE SERVICES LTD
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets432,2169,214
32,2169,214
Current assets
Debtors252,964207,714
Cash at bank and on hand79,85352,989
332,817260,703
Creditors amounts falling due within one year(144,005)(104,847)
Net current assets (liabilities)188,812155,856
Total assets less current liabilities221,028165,070
Creditors amounts falling due after one year(146,713)(130,189)
Net assets74,31534,881
Capital and reserves
Called up share capital55
Profit and loss account74,31034,876
Shareholders' funds74,31534,881
The financial statements were approved and authorised for issue by the Board of Directors on 29 October 2024, and are signed on its behalf by:
GOODWIN, Matthew David
Director
Registered Company No. 08461130
GOODWIN HEALTHCARE SERVICES LTD
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and machinery is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings15
Vehicles25
2.Average number of employees

20242023
Average number of employees during the year9982
3.Intangible assets

Total

£
Cost or valuation
At 01 April 236,000
At 31 March 246,000
Amortisation and impairment
At 01 April 236,000
At 31 March 246,000
Net book value
At 31 March 24-
At 31 March 23-
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 2326,630
Additions40,490
Disposals(22,000)
At 31 March 2445,120
Depreciation and impairment
At 01 April 2317,416
Charge for year11,464
On disposals(15,976)
At 31 March 2412,904
Net book value
At 31 March 2432,216
At 31 March 239,214